|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Restricted Cash | ||||||||||||||||||||
| Receivables, net of allowance for credit losses | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Regulatory Assets | ||||||||||||||||||||
| Other Current Assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Noncurrent Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Property, Plant and Equipment, net of accumulated depreciation | ||||||||||||||||||||
| Regulatory Assets | ||||||||||||||||||||
| Intangible Assets, net of accumulated amortization | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other Noncurrent Assets | ||||||||||||||||||||
| Total Noncurrent Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Short-Term Debt | ||||||||||||||||||||
| Current Maturities of Long-Term Debt | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Accrued Salaries and Wages | ||||||||||||||||||||
| Accrued Taxes | ||||||||||||||||||||
| Regulatory Liabilities | ||||||||||||||||||||
| Other Current Liabilities | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Noncurrent Liabilities | ||||||||||||||||||||
| Pension Benefit Liability | ||||||||||||||||||||
| Other Postretirement Benefits Liability | ||||||||||||||||||||
| Regulatory Liabilities | ||||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||||
| Deferred Tax Credits | ||||||||||||||||||||
| Other Noncurrent Liabilities | ||||||||||||||||||||
| Total Noncurrent Liabilities | ||||||||||||||||||||
| Capitalization | ||||||||||||||||||||
| Long-Term Debt | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common Shares: 50,000,000 shares authorized, $5 par value; 41,985,580 and 41,905,520 outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Income | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Capitalization | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity |
Loading...
